NDC11 73070020310
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 73070-0203-10 | 73070-0203 |
| 73070-203-10 | 73070-203 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Insulin Aspart Protamine and Insulin Aspart Mix 70/30 | INSULIN ASPART | Novo Nordisk Pharma, Inc. | fc94baa4-3606-48bc-a781-9617ab6960ef | 2023-02-28 | Warnings, Adverse reactions | 73070-203-10 73070-203 73070020310 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.